---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-023903"
form_type: "8-K/A"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2026-04-06T23:59:59+00:00"
generated_at: "2026-05-15T07:19:10.718018+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience amends 8-K to correct option repricing share count to 2,458,158

## Summary
- Amendment corrects a scrivener's error: total shares underlying Repriced Options is 2,458,158.
- No other changes to the original April 3, 2026 8-K filing on compensatory arrangements.
- CEO Punit Dhillon signed the amendment dated April 6, 2026.

## SEC filing metadata
- accession: 0001628280-26-023903
- form_type: 8-K/A
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2026-04-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000162828026023903/0001628280-26-023903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000162828026023903/skye-20260331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-023903
- JSON: https://secwatch.observer/filing/0001628280-26-023903.json
- Plain text: https://secwatch.observer/filing/0001628280-26-023903.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.